Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
BioCorRx Inc. (BICX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/05/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "Form of Warrant",
"Form of Subscription Agreement by and between BioCorRx Inc. and each of the Lucido and Galligan Trusts initially effective March 30, 2023",
"Form of Exchange Agreement"
03/31/2023 10-K Annual Report for the period ended December 31, 2022
01/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Form of Murthy Director Agreement",
"Form of Indemnification Agreement"
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/27/2022 8-K Quarterly results
08/15/2022 10-Q Quarterly Report for the period ended June 30, 2022
06/10/2022 8-K Quarterly results
05/16/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/12/2022 8-K Quarterly results
04/28/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "BioCorRx Inc. 2022 Omnibus Securities and Incentive Plan"
03/31/2022 10-K Annual Report for the period ended December 31, 2021
01/19/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Form of Subscription Agreement by and between BioCorRx Inc. and each of the Lucido and Galligan Trusts initially effective January 12, 2022"
09/02/2021 8-K Quarterly results
08/13/2021 10-Q Quarterly Report for the period ended June 30, 2021
05/17/2021 10-Q Quarterly Report for the period ended March 31, 2021
03/31/2021 10-K Annual Report for the period ended December 31, 2020
02/26/2021 8-K Quarterly results
02/22/2021 8-K Quarterly results
11/16/2020 10-Q Quarterly Report for the period ended September 30, 2020
11/13/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/14/2020 10-Q Quarterly Report for the period ended June 30, 2020
05/15/2020 10-Q Quarterly Report for the period ended March 31, 2020
03/30/2020 10-K Annual Report for the period ended December 31, 2019
03/03/2020 8-K Quarterly results
01/30/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "BioCorRx Announces Award of $2.8 Million, the Second Tranche of a NIDA Grant for the Development of BICX102, a Sustained Release Naltrexone Implant for the Treatment of Opioid Use Disorder"
12/09/2019 RW Form RW - Registration Withdrawal Request:
11/14/2019 10-Q Quarterly Report for the period ended September 30, 2019
10/04/2019 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Conversion Agreement, by and between BioCorRx Inc., and BICX Holding Company LLC",
"Lock-Up Agreement, by and between BioCorRx Inc., and BICX Holding Company LLC"
08/14/2019 10-Q Quarterly Report for the period ended June 30, 2019
06/19/2019 8-K Auditor change
Docs: "Letter from Liggett & Webb, PA, to the Securities and Exchange Commission"
06/14/2019 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "MASTER SERVICES AGREEMENT",
"STATEMENT OF WORK 1",
"STATEMENT OF WORK 2"
04/17/2019 SC 13D GALLIGAN JOSEPH J reports a 8.7% stake in BIOCORRX INC.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy